ArticleInvestigative ophthalmology & visual science2026
Pigment Epithelium-Derived Factor From Müller Cells Is Involved in Angiopoietin-Mediated Survival Control of Retinal Neurons.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study was performed to determine whether angiopoietin (Ang)-1 and Ang-2 influence the survival of retinal neurons via Müller cell-mediated mechanisms. Methods: Expression of Ang-1, Ang-2, and Tie-2 in retinal cells and their hypoxia-dependent regulation were investigated using (quantitative) reverse transcription (RT)-PCR (qPCR), immunofluorescence staining, and Western blotting. Survival of Ang-stimulated R28 cells was assessed in homotypic cultures and co-cultures with rat Müller cells (RMCs). Ang-1, Ang-2, PEDF in RMCs and PEDF receptor (PEDF-R) in R28 cells were knocked down by siRNA. Tie-2-PI3 kinase (PI3K)/Akt activation was demonstrated using signaling blockers and by detecting Tie-2-Akt phosphorylation. PEDF expression and secretion were determined by qPCR and ELISA. Results: Ang-1, Ang-2, and Tie-2 are expressed in primary retinal cells, in particular, RMCs and human Müller cells of gliosis tissue. Under hypoxia, Ang-1 and Ang-2 expression declined in RMCs and R28 cell viability was reduced. Although both angiopoietins did not significantly influence R28 cell survival in homotypic cultures, co-cultures with Ang-deficient RMCs revealed that Müller cell-derived Ang-1 promoted, whereas Ang-2 impaired, R28 cell survival. Ang-1 induced Tie-2 and PI3K/Akt activation in RMCs and prevented hypoxia-induced PEDF downregulation. Ang-2 suppressed Tie-2-Akt phosphorylation and PEDF expression. Impaired R28 cell survival under hypoxia or caused by Ang-1 knockdown in co-cultured RMCs was mitigated by Ang-2-deficient RMCs or rescued by supplemental Ang-1 in a PEDF-/PEDF-R-dependent fashion. Conclusions: Ang-regulated signaling and PEDF expression constitute a significant pathway in Müller cells to control retinal neuronal survival. This has implications for effector functions of the therapeutic antibody, Faricimab.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.